Advertisement
Loading...

Cronos Group Inc.

CRON•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$2.63
$-0.11(-4.01%)
U.S. Market opens in 28h 23m

Cronos Group Inc. (CRON) Stock Overview

Explore Cronos Group Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap982.7M
P/E Ratio-505.75
EPS (TTM)$-0.02
ROE-0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$2.27
3 Months$3.22
1 Year Target$3.04

CRON Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cronos Group Inc. (CRON) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.65, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.04.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -505.75 and a market capitalization of 982.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-4.01%
5-Day Change
2.33%
1-Month Change
-3.31%
3-Month Change
1.15%
6-Month Change
7.35%
Year-to-Date (YTD) Change
N/A
1-Year Change
26.44%
3-Year Change
49.43%
5-Year Change
-64.60%
All-Time (Max) Change
1493.94%

Contact Information

https://www.thecronosgroup.com
14165040004
111 Peter Street, Stayner, ON, M5V 2H1

Company Facts

459 Employees
IPO DateFeb 27, 2018
CountryCA
Actively Trading

Frequently Asked Questions